연구개발 새로운 바이오마커와 항암제 개발을 통한 인류의 건강한 미래

Doxorubicin inhibits PD-L1 expression by enhancing TTP-mediated decay of PD-L1 mRNA in cancer cells
  • 작성일2021/01/13 16:22
  • 조회 386

Kim DJ, Jang JH, Ham SY, Choi SH, Park SS, Jeong SY, Kim BC, Jeon DY, Lee BJ, Ko BK, Park JW, Cho WJ.

Doxorubicin inhibits PD-L1 expression by enhancing TTP-mediated decay of PD-L1 mRNA in cancer cells.

Biochem Biophys Res Commun. 2020 Feb 5;522(2):402-407. doi: 10.1016/j.bbrc.2019.11.106. Epub 2019 Nov 23. PMID:31767150